Physician profile
Dawen Bu
NPI 1710154786
$3,329.40
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,663 · 2020: $1,532 · 2021: $134.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $533.74 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $341.84 | 2019-2021 | |
| Ucb, INC. | $268.11 | 2019-2020 | |
| Biogen, INC. | $232.23 | 2019-2021 | |
| Lundbeck LLC | $176.82 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $167.27 | 2019-2020 | |
| Emd Serono, INC. | $166.99 | 2019-2020 | |
| Csl Behring | $124.93 | 2019-2021 | |
| Eisai INC. | $122.81 | 2019-2020 | |
| Genzyme Corporation | $97.52 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $95.57 | 2019 | |
| Genentech USA, INC. | $91.99 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $88.23 | 2019-2020 | |
| Livanova USA, INC. | $83.71 | 2019-2020 | |
| Allergan, INC. | $80.34 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $75.72 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $60.62 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $51.76 | 2019-2020 | |
| Pfizer INC. | $43.32 | 2019 | |
| Avanir Pharmaceuticals, INC. | $41.39 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $36.21 | 2020 | |
| Abbvie INC. | $35.54 | 2019 | |
| Promius Pharma LLC | $31.89 | 2019 | |
| Tanabe Pharma America, INC. | $30.43 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $26.82 | 2020 | |
| Neurelis, INC. | $25.14 | 2020 | |
| Celgene Corporation | $23.42 | 2020 | |
| Lilly USA, LLC | $23.33 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $20.43 | 2020 | |
| Upsher-Smith Laboratories LLC | $19.95 | 2020 | |
| Janssen Pharmaceuticals, INC | $19.58 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.36 | 2019 | |
| Mallinckrodt Enterprises LLC | $16.00 | 2019 | |
| Grifols USA, LLC | $15.82 | 2019 | |
| Kyowa Kirin, INC. | $14.95 | 2020 | |
| Mdd US Operations, LLC | $13.36 | 2019 | |
| Acorda Therapeutics, INC | $13.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawen Bu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.